Computer recognition of the new type of acetylcholine enzyme inhibitor as a potential novel drug for

An international medical study has yielded new findings that have important reference value for disease prevention. Background Alzheimer's disease represents a global public health problem affecting millions of people worldwide. Although there are treatments for specific symptoms, they have not stopped or delayed the development of the disease; therefore, in order to develop new therapeutic alternatives with potential bioavailability, the study applied a computational method based on virtual screening, molecular dynamics simulation and molecular coupling technologies.

Results: Through this study, three compounds have been found to be more similar to Bidozar than to antimony, which has been identified as a reference for antimony. In this study, code 24771824 stands out for its ability to establish pro-hydraulic and aromatic interactions. In contrast, code 151171 and code 21081761 are more preferred for their more directional polar contacts.

It should be pointed out that the above content is based on international public research findings, for reference in HealthCop, and does not constitute clinical advice. If you have any health questions, please consult professional medical personnel.